Skip to content
OpenCapital
Get started

STERIS STE Q4 2026 Annual earnings

Reported May 11, 2026 · After market close

Revenue$1.6BMiss by $6.2MDiluted EPS$2.83Miss by $0.03
Revenue estimate$1.6B
EPS estimate$2.86

Next report

Aug 5, 2026 (In 1 week)
Revenue estimate$1.5B
EPS estimate$2.54

Financials

Q4 2026

Income statement

See full
Revenue$1.6B+7.3%
Gross profit$697.2M+8.8%
Operating income$316.8M+46.6%
Net income$220.2M+51.2%
EPS (diluted)$2.24+52.4%

Balance sheet

See full
Cash & equivalents$439.6M+156%
Total debt$2.1B-10.3%
Total equity$7.2B+8.8%
Total assets$10.7B+5.8%

Cash flow

See full
Operating cash flow$335.4M+28.6%
CapEx$90.2M+27.2%
Free cash flow$245.2M+29.1%

Valuation & ratios

Valuation

as of 07/23/26
See full
Market cap$20.64B-6.2%
Enterprise value$22.28B-5.8%
P/E26.4×-7.7×
P/S3.5×-0.5×

Profitability

See full
Gross margin44.2%+0.2pp
Operating margin18.6%+2.7pp
Net margin13.2%+1.9pp
FCF margin16.4%+2.1pp

Returns & leverage

See full
Return on equity11.3%+1.8pp
Debt / equity0.3×-0.1×
Current ratio2.1×+0.1×

Segments

By product

See full
Service$745.0M+9.4%
Consumables$456.2M+6.4%
Capital equipment$387.0M+4.3%

By segment

See full
Healthcare Segment$1.1B+7.5%
AST$289.2M+5.6%

Versus estimates

Revenue

Q4 2026$1.6BMiss by $6.2M
Q3 2026$1.5BBeat by $15.3MQ2 2026$1.5BBeat by $28.9MQ1 2026$1.4BBeat by $28.4MQ4 2025$1.5BBeat by $11.5MQ3 2025$1.4BMiss by $11.3M

Diluted EPS

Q4 2026$2.83Miss by $0.03
Q3 2026$2.53In lineQ2 2026$2.47Beat by $0.12Q1 2026$2.34Beat by $0.08Q4 2025$2.74Beat by $0.14Q3 2025$2.32Miss by $0.01

Ask the moment STERIS reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did STERIS report Q4 2026 earnings?
STERIS (STE) reported Q4 2026 earnings on May 11, 2026 after market close.
What were STERIS's Q4 2026 revenue and EPS?
STERIS reported revenue of $1.6B and diluted EPS of $2.83 for Q4 2026.
Did STERIS beat estimates in Q4 2026?
Revenue missed the consensus estimate of $1.6B by $6.2M. EPS missed the consensus estimate of $2.86 by $0.03.
How did STERIS's Q4 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 7.3% from $1.5B a year earlier and diluted EPS grew 3.3% from $2.74.
Where can I find STERIS's Q4 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-033580) and the 10-K periodic report (0001628280-26-039136) directly on SEC EDGAR. The filing index links above go to sec.gov.